Department of Breast Oncology, National Kyushu Cancer Center, Notame 3-1-1 Minami-ku, Fukuoka, 811-1395, Japan,
Breast Cancer. 2013 Oct;20(4):291-5. doi: 10.1007/s12282-012-0420-8. Epub 2013 Mar 15.
The purpose of this article is to describe the current status and future perspectives of the Japan Breast Cancer Research Group (JBCRG). The JBCRG was organized in 2002, with the following purpose: to plan and promote clinical trials and basic research in breast cancer domestically and multilaterally; to conduct research and surveys on domestic and foreign information on medical care for breast cancer and to diffuse and highlight such information; to improve and promote clinical technologies for breast cancer; to act as an intermediary to liaise and strengthen alliances with affiliated organizations; and, to contribute to the public welfare by improving outcomes in breast cancer. The clinical trials are led by doctors/investigators in the JBCRG. And the purpose is to establish standard treatment for patients and provide substantial evidence. The JBCRG implements international collaboration in some researches/studies. As of January 2012, fourteen trials have been closed and nine are open to recruitment.
本文旨在介绍日本乳腺癌研究组（JBCRG）的现状和未来展望。JBCRG 成立于 2002 年，宗旨如下：计划并在国内外推动乳腺癌的临床试验和基础研究；开展乳腺癌国内外医疗信息的研究和调查，并传播和突出此类信息；提高和促进乳腺癌的临床技术；充当联络人，加强与附属组织的联盟；通过改善乳腺癌的结果来为公益事业做出贡献。临床试验由 JBCRG 的医生/研究人员主导。目的是为患者建立标准治疗方法并提供实质性证据。JBCRG 在一些研究/调查中实施国际合作。截至 2012 年 1 月，已完成 14 项试验，9 项正在招募中。
